{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:01:56Z","timestamp":1792101716850,"version":"4.4.0"},"reference-count":69,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Autism spectrum disorder (ASD) is a common neurodevelopmental disorder affecting 2% of children in the United States. Biochemical abnormalities associated with ASD include impaired methylation and sulphation capacities along with low glutathione (GSH) redox capacity. Potential treatments for these abnormalities include cobalamin (B12). This systematic review collates the studies using B12 as a treatment in ASD. A total of 17 studies were identified; 4 were double-blind, placebo-controlled studies (2 examined B12 injections alone and 2 used B12 in an oral multivitamin); 1 was a prospective controlled study; 6 were prospective, uncontrolled studies, and 6 were retrospective (case series and reports). Most studies (83%) used oral or injected methylcobalamin (mB12), while the remaining studies did not specify the type of B12 used. Studies using subcutaneous mB12 injections (including 2 placebo-controlled studies) used a 64.5\u201375 \u00b5g\/kg\/dose. One study reported anemia in 2 ASD children with injected cyanocobalamin that resolved with switching to injected mB12. Two studies reported improvements in markers of mitochondrial metabolism. A meta-analysis of methylation metabolites demonstrated decreased S-adenosylhomocysteine (SAH), and increased methionine, S-adenosylmethionine (SAM), SAM\/SAH ratio, and homocysteine (with small effect sizes) with mB12. Meta-analysis of the transsulfuration and redox metabolism metabolites demonstrated significant improvements with mB12 in oxidized glutathione (GSSG), cysteine, total glutathione (GSH), and total GSH\/GSSG redox ratio with medium to large effect sizes. Improvements in methylation capacity and GSH redox ratio were significantly associated with clinical improvements (with a mean moderate effect size of 0.59) in core and associated ASD symptoms, including expressive communication, personal and domestic daily living skills, and interpersonal, play-leisure, and coping social skills, suggesting these biomarkers may predict response to B12. Other clinical improvements observed with B12 included sleep, gastrointestinal symptoms, hyperactivity, tantrums, nonverbal intellectual quotient, vision, eye contact, echolalia, stereotypy, anemia, and nocturnal enuresis. Adverse events identified by meta-analysis included hyperactivity (11.9%), irritability (3.4%), trouble sleeping (7.6%), aggression (1.8%), and worsening behaviors (7.7%) but were generally few, mild, not serious, and not significantly different compared to placebo. In one study, 78% of parents desired to continue mB12 injections after the study conclusion. Preliminary clinical evidence suggests that B12, particularly subcutaneously injected mB12, improves metabolic abnormalities in ASD along with clinical symptoms. Further large multicenter placebo-controlled studies are needed to confirm these data. B12 is a promising treatment for ASD.<\/jats:p>","DOI":"10.3390\/jpm11080784","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T08:35:52Z","timestamp":1628670952000},"page":"784","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["The Effectiveness of Cobalamin (B12) Treatment for Autism Spectrum Disorder: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4405-8664","authenticated-orcid":false,"given":"Daniel A.","family":"Rossignol","sequence":"first","affiliation":[{"name":"Rossignol Medical Center, 24541 Pacific Park Drive, Suite 210, Aliso Viejo, CA 92656, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4442-2937","authenticated-orcid":false,"given":"Richard E.","family":"Frye","sequence":"additional","affiliation":[{"name":"Barrow Neurological Institute at Phoenix Children\u2019s Hospital, 1919 E Thomas Rd, Phoenix, AZ 85016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,11]]},"reference":[{"key":"ref_1","first-page":"1","article-title":"Prevalence of autism spectrum disorder among children aged 8 years\u2014Autism and developmental disabilities monitoring network, 11 sites, United States, 2016","volume":"69","author":"Maenner","year":"2020","journal-title":"Morb. Mortal. Wkly. Rep. Surveill. Summ."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3389\/fncel.2018.00405","article-title":"Immune dysfunction and autoimmunity as pathological mechanisms in autism spectrum disorders","volume":"12","author":"Hughes","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/mp.2010.136","article-title":"Mitochondrial dysfunction in autism spectrum disorders: A systematic review and meta-analysis","volume":"17","author":"Rossignol","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s40291-018-0352-x","article-title":"Clinical and molecular characteristics of mitochondrial dysfunction in autism spectrum disorder","volume":"22","author":"Rose","year":"2018","journal-title":"Mol. Diagn. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41398-020-01135-3","article-title":"Oxidative stress marker aberrations in children with autism spectrum disorder: A systematic review and meta-analysis of 87 studies (N = 9109)","volume":"11","author":"Chen","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.yebeh.2019.07.037","article-title":"The co-occurrence of epilepsy and autism: A systematic review","volume":"98","author":"Lukmanji","year":"2019","journal-title":"Epilepsy Behav."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.chc.2020.02.005","article-title":"Gastrointestinal Issues and autism spectrum disorder","volume":"29","author":"Madra","year":"2020","journal-title":"Child Adolesc. Psychiatr. Clin. N. Am."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/ajcn\/80.6.1611","article-title":"Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism","volume":"80","author":"James","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/ajmg.b.30366","article-title":"Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism","volume":"141B","author":"James","year":"2006","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10803-011-1260-7","article-title":"Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism","volume":"42","author":"Melnyk","year":"2012","journal-title":"J. Autism Dev. Disord."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3945\/ajcn.2008.26615","article-title":"Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism","volume":"89","author":"James","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"A348","DOI":"10.1096\/fasebj.21.5.A348-a","article-title":"Elevation in S-adenosylhomocysteine and DNA hypomethylation in parents and children with autism","volume":"21","author":"Melnyk","year":"2007","journal-title":"FASEB J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/mp.2013.114","article-title":"Common DNA methylation alterations in multiple brain regions in autism","volume":"19","author":"Hansen","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e433","DOI":"10.1038\/tp.2014.70","article-title":"DNA methylation analysis of the autistic brain reveals multiple dysregulated biological pathways","volume":"4","author":"Nardone","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1038\/tp.2012.61","article-title":"Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain","volume":"2","author":"Rose","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/acps.13170","article-title":"Blood biomarker levels of methylation capacity in autism spectrum disorder: A systematic review and meta-analysis","volume":"141","author":"Guo","year":"2020","journal-title":"Acta. Psychiatr. Scand."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/aur.2310","article-title":"DNA methylation associated with mitochondrial dysfunction in a south african autism spectrum disorder cohort","volume":"13","author":"Stathopoulos","year":"2020","journal-title":"Autism Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Howsmon, D.P., Kruger, U., Melnyk, S., James, S.J., and Hahn, J. (2017). Classification and adaptive behavior prediction of children with autism spectrum disorder based upon multivariate data analysis of markers of oxidative stress and DNA methylation. PLoS Comput. Biol., 13.","DOI":"10.1371\/journal.pcbi.1005385"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.18388\/abp.2011_2223","article-title":"Hyperhomocysteinemia among omani autistic children: A case-control study","volume":"58","author":"Ali","year":"2011","journal-title":"Acta. Biochim. Pol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.9758\/cpn.2018.16.4.383","article-title":"The levels of vitamin D, vitamin D receptor, homocysteine and complex B vitamin in children with autism spectrum disorders","volume":"16","author":"Altun","year":"2018","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/1871530318666180213110815","article-title":"Homocysteine levels in autism spectrum disorder: A clinical update","volume":"18","author":"Cauli","year":"2018","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"113283","DOI":"10.1016\/j.psychres.2020.113283","article-title":"Blood homocysteine levels in children with autism spectrum disorder: An updated systematic review and meta-analysis","volume":"291","author":"Guo","year":"2020","journal-title":"Psychiatry Res."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Muratore, C.R., Hodgson, N.W., Trivedi, M.S., Abdolmaleky, H.M., Persico, A.M., Lintas, C., De la Monte, S., and Deth, R.C. (2013). Age-dependent decrease and alternative splicing of methionine synthase mRNA in human cerebral cortex and an accelerated decrease in autism. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0056927"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"532640","DOI":"10.1155\/2009\/532640","article-title":"The severity of autism is associated with toxic metal body burden and red blood cell glutathione levels","volume":"2009","author":"Adams","year":"2009","journal-title":"J. Toxicol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1096\/fj.08-128926","article-title":"Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism","volume":"23","author":"James","year":"2009","journal-title":"FASEB J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s11064-012-0775-4","article-title":"Brain region-specific glutathione redox imbalance in autism","volume":"37","author":"Chauhan","year":"2012","journal-title":"Neurochem. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0006-3223(98)00337-0","article-title":"Sulphation deficit in \u201clow-functioning\u201d autistic children: A pilot study","volume":"46","author":"Alberti","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"ref_28","first-page":"40","article-title":"Biochemical parameters in autistic children","volume":"10","author":"Waring","year":"1997","journal-title":"Dev. Brain Dysfunct."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/13590840050000861","article-title":"Sulphur metabolism in autism","volume":"10","author":"Waring","year":"2000","journal-title":"J. Nutr. Environ. Med."},{"key":"ref_30","first-page":"42","article-title":"Comparative bioavailability and utilization of particular forms of B12 supplements with potential to mitigate B12-related genetic polymorphisms","volume":"16","author":"Paul","year":"2017","journal-title":"Integr. Med. Clin. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF02343237","article-title":"Vitamin B12 and brain development","volume":"146","author":"Stollhoff","year":"1987","journal-title":"Eur. J. Pediatr."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s10803-013-1762-6","article-title":"Brief report: Childhood disintegrative disorder as a likely manifestation of vitamin B12 deficiency","volume":"43","author":"Malhotra","year":"2013","journal-title":"J. Autism Dev. Disord."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_34","unstructured":"Higgins, J.P.T., and Green, S. (2011). Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions, The Cochrane Collaboration. [5.1.0 ed.]."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1089\/cap.2015.0159","article-title":"Randomized, placebo-controlled trial of methyl B12 for children with autism","volume":"26","author":"Hendren","year":"2016","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"ref_36","first-page":"236","article-title":"The way in which intervention studies have \u201cpersonality\u201d and why it is important to meta-analysis","volume":"24","author":"Lipsey","year":"2001","journal-title":"Eval. Health Prof."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/sim.2639","article-title":"Trying to be precise about vagueness","volume":"26","author":"Senn","year":"2007","journal-title":"Stat. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cct.2015.05.009","article-title":"Advances in the meta-analysis of heterogeneous clinical trials I: The inverse variance heterogeneity model","volume":"45","author":"Doi","year":"2015","journal-title":"Contemp. Clin. Trials"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Cohen, J. (2013). Statistical Power Analysis for the Behavioral Sciences, Lawrence Erlbaum Associates. [2nd ed.].","DOI":"10.4324\/9780203771587"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/jech-2013-203104","article-title":"Meta-analysis of prevalence","volume":"67","author":"Barendregt","year":"2013","journal-title":"J. Epidemiol. Community Health"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/XEB.0000000000000141","article-title":"A new improved graphical and quantitative method for detecting bias in meta-analysis","volume":"16","author":"Barendregt","year":"2018","journal-title":"Int. J. Evid. Based Healthc."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.nutres.2011.03.009","article-title":"Vitamin supplementation reduces the level of homocysteine in the urine of autistic children","volume":"31","author":"Michalska","year":"2011","journal-title":"Nutr. Res."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Delhey, L.M., Nur Kilinc, E., Yin, L., Slattery, J.C., Tippett, M.L., Rose, S., Bennuri, S.C., Kahler, S.G., Damle, S., and Legido, A. (2017). The effect of mitochondrial supplements on mitochondrial activity in children with autism spectrum disorder. J. Clin. Med., 6.","DOI":"10.3390\/jcm6020018"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e967","DOI":"10.1542\/peds.2009-2975","article-title":"Vitamin B12 optic neuropathy in autism","volume":"126","author":"Pineles","year":"2010","journal-title":"Pediatrics"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e1699","DOI":"10.1542\/peds.2012-3054","article-title":"Pulmonary hypertension associated with scurvy and vitamin deficiencies in an autistic child","volume":"132","author":"Duvall","year":"2013","journal-title":"Pediatrics"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1089\/acm.2004.10.1033","article-title":"Pilot study of a moderate dose multivitamin\/mineral supplement for children with autistic spectrum disorder","volume":"10","author":"Adams","year":"2004","journal-title":"J. Altern. Complementary Med."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Adams, J.B., Audhya, T., McDonough-Means, S., Rubin, R.A., Quig, D., Geis, E., Gehn, E., Loresto, M., Mitchell, J., and Atwood, S. (2011). Effect of a vitamin\/mineral supplement on children and adults with autism. BMC Pediatr., 11.","DOI":"10.1186\/1471-2431-11-111"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Adams, J.B., Audhya, T., Geis, E., Gehn, E., Fimbres, V., Pollard, E.L., Mitchell, J., Ingram, J., Hellmers, R., and Laake, D. (2018). Comprehensive nutritional and dietary intervention for autism spectrum disorder\u2014A randomized, controlled 12-month trial. Nutrients, 10.","DOI":"10.3390\/nu10030369"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e430","DOI":"10.1097\/MPH.0000000000000857","article-title":"Long-term outcome of 4 patients with transcobalamin deficiency caused by 2 novel TCN2 mutations","volume":"39","author":"Nashabat","year":"2017","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_52","first-page":"64","article-title":"A preliminary study of methylcobalamin therapy in autism","volume":"75","author":"Nakano","year":"2005","journal-title":"J. Tokyo Women\u2019s Med. Univ."},{"key":"ref_53","first-page":"609705","article-title":"Effectiveness of methylcobalamin and folinic acid treatment on adaptive behavior in children with autistic disorder is related to glutathione redox status","volume":"2013","author":"Frye","year":"2013","journal-title":"Autism Res. Treat."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1089\/cap.2014.0023","article-title":"Cessation of nocturnal enuresis after intervention with methylcobalamin in an 18-year-old patient with autism","volume":"25","author":"Corejova","year":"2015","journal-title":"J. Child. Adolesc. Psychopharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/acm.2009.0177","article-title":"Pilot study of the effect of methyl B12 treatment on behavioral and biomarker measures in children with autism","volume":"16","author":"Bertoglio","year":"2010","journal-title":"J. Altern. Complementary Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1080\/02772240903187205","article-title":"An autism cohort study of cobalt levels following vitamin B12 injections","volume":"92","author":"Geier","year":"2010","journal-title":"Toxicol. Environ. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.freeradbiomed.2012.03.011","article-title":"Oxidative stress-related biomarkers in autism: Systematic review and meta-analyses","volume":"52","author":"Frustaci","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Hodgson, N.W., Trivedi, M.S., Abdolmaleky, H.M., Fournier, M., Cuenod, M., Do, K.Q., and Deth, R.C. (2016). Decreased brain levels of vitamin B12 in aging, autism and schizophrenia. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0146797"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fphys.2014.00150","article-title":"Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism","volume":"5","author":"Rossignol","year":"2014","journal-title":"Front. Physiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fnins.2016.00192","article-title":"Neuropathological mechanisms of seizures in autism spectrum disorder","volume":"10","author":"Frye","year":"2016","journal-title":"Front. Neurosci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fped.2014.00087","article-title":"The use of medications approved for alzheimer\u2019s disease in autism spectrum disorder: A systematic review","volume":"2","author":"Rossignol","year":"2014","journal-title":"Front. Pediatrics"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fnins.2016.00080","article-title":"Blocking and binding folate receptor alpha autoantibodies identify novel autism spectrum disorder subgroups","volume":"10","author":"Frye","year":"2016","journal-title":"Front. Neurosci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"100835","DOI":"10.1016\/j.spen.2020.100835","article-title":"Treatment of folate metabolism abnormalities in autism spectrum disorder","volume":"35","author":"Frye","year":"2020","journal-title":"Semin. Pediatr. Neurol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1177\/1362361318794179","article-title":"Differences in food consumption and nutritional intake between children with autism spectrum disorders and typically developing children: A meta-analysis","volume":"23","author":"Canals","year":"2019","journal-title":"Autism"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s10803-013-1771-5","article-title":"Feeding problems and nutrient intake in children with autism spectrum disorders: A meta-analysis and comprehensive review of the literature","volume":"43","author":"Sharp","year":"2013","journal-title":"J. Autism Dev. Disord."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2337\/diacare.23.9.1227","article-title":"Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin","volume":"23","author":"Bauman","year":"2000","journal-title":"Diabetes Care"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"5987","DOI":"10.1038\/s41598-019-42568-1","article-title":"A molecular biomarker for prediction of clinical outcome in children with ASD, constipation, and intestinal inflammation","volume":"9","author":"Walker","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jpeds.2017.04.004","article-title":"Increased serum zonulin levels as an intestinal permeability marker in autistic subjects","volume":"188","author":"Esnafoglu","year":"2017","journal-title":"J. Pediatr."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tox.2017.05.015","article-title":"Cobalt toxicity in humans\u2014A review of the potential sources and systemic health effects","volume":"387","author":"Leyssens","year":"2017","journal-title":"Toxicology"}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/8\/784\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:44:06Z","timestamp":1760165046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/8\/784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,11]]},"references-count":69,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["jpm11080784"],"URL":"https:\/\/doi.org\/10.3390\/jpm11080784","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,11]]}}}